Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label study of CN-801 (modafinil) in idiopathic hypersomnia with excessive daytime sleepiness
jRCT2080222564Phase 3
- Sponsor
- Alfresa
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of modafinil in hypersomnolence disorder, sponsored by Alfresa.
02
Drugs
modafinil
03
Conditions
hypersomnolence disorder
Beyond the preview
Go deeper on jRCT2080222564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222564.